- Home >
- Clinicals Trials >
- AML LI-1
Retour à la liste des essais cliniques
AML LI-1
A PROGRAMME OF DEVELOPMENT FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME
- Ouvert à Saint-Cloud depuis le : 03/04/2014
- Public cible : Adult
- Phase : Phase II/III
Description de l'essai
The LI-1 Protocol is an international ongoing therapeutic evaluation program for elderly patients with high-risk AML and MDS who are considered ineligible for conventional intensive chemotherapy. Patients are initially included in a randomized multi-arm Phase II trial, which compares multiple new therapeutic options to the standard treatment (low-dose Aracytine).
Investigateur principal
